In our study, the diagnostic performance of AFP and PIVKA-II in the CHB cohort was comparable to that observed in the CHC cohort, suggesting that both biomarkers demonstrate similar utility across chronic viral hepatitis etiologies. The gene discussed is AFP; the disease is animal viral hepatitis.